Intranasal CRISPR-lipid nanoparticles targeting MAPK9 reduce neuroinflammation after traumatic brain injury.
Telomerase mRNA-Lipid nanoparticles attenuate neuroinflammation after traumatic brain injury in mice.
Reply: Genetically proxied GLP1R expression does not predict exenatide response in the Exenatide-PD3 trial.
Correction: Neurological diagnoses in hospitalized COVID-19 patients associated with adverse outcomes: A multinational cohort study.
SpatialQuery: scalable discovery and molecular characterization of multicellular motifs from spatial omics data.
